비교리스트

 카트 문의
시장보고서
상품코드
1193067

두개내 동맥류 시장 : 유형별(외과적 클리핑, 혈관내 코일, 혈류 전환기, 기타), 최종 사용자별(병원, 진료소, 기타) - 세계 기회 분석 및 산업 예측(2021-2031년)

Intracranial Aneurysm Market By Type (Surgical Clipping, Endovascular Coiling, Flow Diverters, Others), By End User (Hospitals, Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
발행일: | 리서치사: Allied Market Research | 페이지 정보: 영문 243 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 두개내 동맥류 시장은 2021년에 13억 189만 달러로 평가되었으며, 2031년에는 27억 979만 달러에 이르렀으며, 2022년부터 2031년까지의 CAGR은 7.6%로 예측되었다.

뇌동맥 또는 두개내 동맥류는 혈관벽 내부의 근육층(내막)의 약화로 인한 뇌동맥의 비정상적인 국소 확장이며, 이 확장은 뇌동맥류의 원인이 됩니다. 혈관은 "물집"과 같은 팽창을 일으켜 얇아지며 촉감없이 파열 될 수 있습니다. 그 결과, 뇌 주위의 공간에 출혈해, 이것을 거미막하 출혈(SAH)이라고 부릅니다. 이러한 출혈은 뇌졸중, 혼수, 사망으로 이어질 수 있습니다.

동맥류는 대개 뇌의 바닥, 두개골 바로 안쪽, 거미막 하강이라는 영역에 존재합니다. 실제로 지주막하 출혈(SAH)의 90%는 뇌동맥류 파열로 인한 것입니다. 그러나 뇌동맥류의 형성에는 고혈압, 흡연, 선천성 소인, 혈관 손상·외상, 특정 혈액 감염에 의한 합병증 등 다양한 요인이 있다고 생각되고 있습니다.

시장 성장을 견인하는 주요 요인으로는 뇌혈관 장애 환자 수의 증가와 고혈압을 앓는 노년 인구의 급증 등이 있습니다. 예를 들어, 뇌동맥류 재단이 발표한 보고서에 따르면 미국에서는 파열되지 않은 뇌동맥류를 가진 사람이 650만 명, 즉 50명 중 1명인 것으로 추정된다. 또한 연간 파열률은 10만명당 약 8-10명이며, 미국에서는 매년 약 3만명이 뇌동맥류의 파열에 시달리고 있습니다. 게다가, 남성보다 여성이 뇌동맥류가 되기 쉽고(3 : 2의 비율), 특히 55세 이상의 분은 남성보다 뇌동맥류 파열의 리스크가 높다(약 1.5배의 리스크) 것이 보고되었습니다. 뇌동맥류에 의한 사망자는 세계에서 연간 50만명 가까이 있으며, 그 절반은 50세 이하의 젊은층이다. 뇌혈관질환은 고혈압이나 흡연, 건강에 해로운 생활습관 등에 의해 혈관이 손상되어 뇌동맥류가 생기는 것이 원인으로 되어 있습니다. 또한, 낮은 침습 수술에 대한 수요 증가는 작은 절개는 수술 후 통증을 줄이고 개두 수술에 대한 이러한 절차의 높은 채용으로 이어지는 빠른 회복을 용이하게하기 위해 시장 성장을 밀어주세요. 많은 주요 기업들이 혁신적인 저침습 혈관내 코일링 기구 출시를 위한 연구개발 활동에 지속적으로 투자하고 있으며 시장 성장을 촉진할 것으로 예상됩니다.

그러나 동맥류로 인한 지주막 하 출혈의 관리 비용이 높고 수술 중 건강 위험이 높아 시장 성장을 방해하고 있습니다. 한편, 기본 의료를 받을 수 없는 개발도상국이나 저소득국의 신흥 헬스케어 시장, 유행성 및 고혈압 관련 질환의 리스크의 증가는, 예측 기간중에 시장 성장을 위한 유리한 기회를 제공할 것으로 예상 됩니다.

목차

제1장 소개

제2장 주요 요약

제3장 시장 개요

  • 시장의 정의와 범위
  • 주요 조사 결과
    • 주요 투자 포켓
  • Porter's Five Forces 분석
  • 주요 기업의 포지셔닝
  • 시장 역학
    • 촉진 요인
    • 억제 요인
    • 기회
  • COVID-19 영향 분석

제4장 두개내 동맥류 시장 : 유형별

  • 개요
    • 시장 규모 및 예측
  • 외과 수술용 클리핑
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별
  • 혈관내 코일링
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별
  • 혈류 전환기
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별
  • 기타
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별

제5장 두개내 동맥류 시장 : 최종 사용자별

  • 개요
    • 시장 규모·예측
  • 병원
    • 주요 시장 동향, 성장 요인과 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별
  • 진료소
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별
  • 기타
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별

제6장 두개내 동맥류 시장 : 지역별

  • 개요
    • 시장 규모·예측
  • 북미
    • 주요 동향과 기회
    • 북미 시장 규모·예측 : 유형별
    • 북미 시장 규모·예측 : 최종 사용자별
    • 북미 시장 규모·예측 : 국가별
      • 미국
      • 캐나다
      • 멕시코
  • 유럽
    • 주요 동향과 기회
    • 유럽 시장 규모·예측 : 유형별
    • 유럽 시장 규모·예측 : 최종 사용자별
    • 유럽 시장 규모·예측 : 국가별
      • 독일
      • 프랑스
      • 영국
      • 이탈리아
      • 스페인
      • 기타 유럽
  • 아시아태평양
    • 주요 동향과 기회
    • 아시아태평양의 시장 규모·예측 : 유형별
    • 아시아태평양의 시장 규모·예측 : 최종 사용자별
    • 아시아태평양의 시장 규모·예측 : 국가별
      • 일본
      • 중국
      • 호주
      • 인도
      • 한국
      • 기타 아시아태평양
  • LAMEA
    • 주요 동향과 기회
    • LAMEA의 시장 규모·예측 : 유형별
    • LAMEA의 시장 규모·예측 : 엔드유저별
    • LAMEA의 시장 규모·예측 : 국가별
      • 브라질
      • 사우디아라비아
      • 남아프리카 공화국
      • 기타 LAMEA

제7장 기업 정세

  • 소개
  • 주요 성공 전략
  • 주요 10개사의 제품 매핑
  • 경쟁 대시보드
  • 경쟁 히트맵
  • 주요 발전

제8장 기업 프로필

  • B. Braun
  • Delta Surgical
  • Evonos GmbH & Co. KG
  • Integra Life-science Holding Corporation
  • Medtronic PLC
  • Microport Scientific Corporation
  • Mizuho Medical Incorporation
  • Spiegelberg
  • Stryker Corporation
  • Terumo Global(Microvention)
ksm 23.03.27

The global intracranial aneurysm market was valued at $1,301.89 million in 2021, and is projected to reach $2,709.79 million by 2031, registering a CAGR of 7.6% from 2022 to 2031.A cerebral or intracranial aneurysm is an abnormal focal dilation of an artery in the brain that results from weakening of the inner muscular layer (the intima) of a blood vessel wall. The vessel develops a "blister-like" dilation that can become thin and rupture without warning. This results in bleeding into the space around the brain, which is called a subarachnoid hemorrhage (SAH). This kind of hemorrhage can lead to a stroke, coma, and/or death.

Aneurysms are usually found at the base of brain, just inside the skull, in an area called subarachnoid space. In fact, ruptured cerebral aneurysms are responsible for 90% of subarachnoid hemorrhage (SAH). However, a number of factors are believed to contribute in formation of cerebral aneurysms, including hypertension, smoking, congenital predisposition, injury, or trauma to blood vessels and complications from some types of blood infections.

Key factors that drive growth of the market include rise in number of patients suffering from cerebrovascular disease and surge in geriatric population suffering from hypertension. For instance, according to a report published by the Brain Aneurysm Foundation, it has been estimated that 6.5 million people in the U.S. have an unruptured brain aneurysm i.e., 1 in 50 people. The annual rate of rupture is approximately 8-10 per 100,000 people and around 30,000 people in the U.S. suffer a brain aneurysm rupture each year. Moreover, it has been reported that women are more likely than men to have a brain aneurysm (3:2 ratio), particularly those over the age of 55 have a higher risk of brain aneurysm rupture than men (about 1.5 times the risk). There are almost 500,000 deaths worldwide each year caused by brain aneurysms, and half the victims are younger than 50. The reason behind rise in prevalence of cerebrovascular disease are hypertension, cigarette smoking, and unhealthy lifestyle which leads to injury or trauma to blood vessels causing brain aneurysm. Furthermore, rise in the demand for minimally invasive surgeries, as smaller incisions decrease postoperative pain and facilitate speedy recovery leading to high adoption of these procedures for craniotomy surgery boost the market growth. Numerous key players are continuously investing in R&D activities for the launch of innovative minimally invasive endovascular coiling instruments are anticipated to fuel the market growth.

However, high management cost of aneurysm subarachnoid hemorrhage and high health risk during surgeries hamper the market growth. Conversely, emerging healthcare markets in developing countries and low-income countries lacking access to basic healthcare and increase in risk of pandemic and hypertension related disorders is expected to provide the lucrative opportunity for the growth of market during the forecast period. 

The intracranial aneurysm market is segmented on the basis of type, end user, and region. By type the market is segmented into surgical clipping, endovascular coiling, flow diverters, and others. By end user, it segmented into hospitals, clinics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

North America accounted for a majority of the intracranial aneurysm market share in 2021, and is anticipated to remain dominant during the forecast period, owing to the presence of well-established healthcare facilities, a growing geriatric population, and a high incidence of hypertension and stroke. Moreover, increase in prevalence of intracranial aneurysms and rise in demand for minimally invasive procedures contribute toward the market growth in the region. Furthermore, increase in number of initiatives undertaken by various organizations to spread awareness and reduce number of deaths due to cerebral aneurysms through innovative research is expected to fuel the market growth.

Asia-Pacific is expected to register fastest CAGR during the forecast period. This is attributed to presence of high unmet medical needs and constantly improving healthcare infrastructure. In addition, rapidly growing geriatric population, lifestyle stress, rise in incidences of hypertension, large population, improvement in quality of diagnosis, and increase in patient affordability are expected to drive the market in Asia-Pacific. This helps several market players to invest in Asia-Pacific countries, which further contributes toward growth of the market.

Key players that operate in the Intracranial aneurysm market are B. Braun, Delta Surgical, Evonos GmbH & Co. KG, Integra Lifescience Holding Corporation, Medtronic PLC, Microport Scientific Corporation, Mizuho Medical Incorporation, Spiegelberg, Stryker Corporation, and Terumo Global (Microvention).

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the intracranial aneurysm market analysis from 2021 to 2031 to identify the prevailing intracranial aneurysm market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the intracranial aneurysm market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global intracranial aneurysm market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Surgical Clipping
  • Endovascular Coiling
  • Flow Diverters
  • Others

By End User

  • Hospitals
  • Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Rest of Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • B. Braun
    • Delta Surgical
    • Evonos GmbH & Co. KG
    • Integra Life-science Holding Corporation
    • Medtronic PLC
    • Microport Scientific Corporation
    • Mizuho Medical Incorporation
    • Spiegelberg
    • Stryker Corporation
    • Terumo Global (Microvention)

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: INTRACRANIAL ANEURYSM MARKET, BY TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Surgical Clipping
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Endovascular Coiling
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
  • 4.4 Flow Diverters
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market analysis by country
  • 4.5 Others
    • 4.5.1 Key market trends, growth factors and opportunities
    • 4.5.2 Market size and forecast, by region
    • 4.5.3 Market analysis by country

CHAPTER 5: INTRACRANIAL ANEURYSM MARKET, BY END USER

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Hospitals
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Clinics
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Others
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country

CHAPTER 6: INTRACRANIAL ANEURYSM MARKET, BY REGION

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 North America
    • 6.2.1 Key trends and opportunities
    • 6.2.2 North America Market size and forecast, by Type
    • 6.2.3 North America Market size and forecast, by End User
    • 6.2.4 North America Market size and forecast, by country
      • 6.2.4.1 U.S.
      • 6.2.4.1.1 Market size and forecast, by Type
      • 6.2.4.1.2 Market size and forecast, by End User
      • 6.2.4.2 Canada
      • 6.2.4.2.1 Market size and forecast, by Type
      • 6.2.4.2.2 Market size and forecast, by End User
      • 6.2.4.3 Mexico
      • 6.2.4.3.1 Market size and forecast, by Type
      • 6.2.4.3.2 Market size and forecast, by End User
  • 6.3 Europe
    • 6.3.1 Key trends and opportunities
    • 6.3.2 Europe Market size and forecast, by Type
    • 6.3.3 Europe Market size and forecast, by End User
    • 6.3.4 Europe Market size and forecast, by country
      • 6.3.4.1 Germany
      • 6.3.4.1.1 Market size and forecast, by Type
      • 6.3.4.1.2 Market size and forecast, by End User
      • 6.3.4.2 France
      • 6.3.4.2.1 Market size and forecast, by Type
      • 6.3.4.2.2 Market size and forecast, by End User
      • 6.3.4.3 UK
      • 6.3.4.3.1 Market size and forecast, by Type
      • 6.3.4.3.2 Market size and forecast, by End User
      • 6.3.4.4 Italy
      • 6.3.4.4.1 Market size and forecast, by Type
      • 6.3.4.4.2 Market size and forecast, by End User
      • 6.3.4.5 Spain
      • 6.3.4.5.1 Market size and forecast, by Type
      • 6.3.4.5.2 Market size and forecast, by End User
      • 6.3.4.6 Rest of Europe
      • 6.3.4.6.1 Market size and forecast, by Type
      • 6.3.4.6.2 Market size and forecast, by End User
  • 6.4 Asia-Pacific
    • 6.4.1 Key trends and opportunities
    • 6.4.2 Asia-Pacific Market size and forecast, by Type
    • 6.4.3 Asia-Pacific Market size and forecast, by End User
    • 6.4.4 Asia-Pacific Market size and forecast, by country
      • 6.4.4.1 Japan
      • 6.4.4.1.1 Market size and forecast, by Type
      • 6.4.4.1.2 Market size and forecast, by End User
      • 6.4.4.2 China
      • 6.4.4.2.1 Market size and forecast, by Type
      • 6.4.4.2.2 Market size and forecast, by End User
      • 6.4.4.3 Australia
      • 6.4.4.3.1 Market size and forecast, by Type
      • 6.4.4.3.2 Market size and forecast, by End User
      • 6.4.4.4 India
      • 6.4.4.4.1 Market size and forecast, by Type
      • 6.4.4.4.2 Market size and forecast, by End User
      • 6.4.4.5 South Korea
      • 6.4.4.5.1 Market size and forecast, by Type
      • 6.4.4.5.2 Market size and forecast, by End User
      • 6.4.4.6 Rest of Asia-Pacific
      • 6.4.4.6.1 Market size and forecast, by Type
      • 6.4.4.6.2 Market size and forecast, by End User
  • 6.5 LAMEA
    • 6.5.1 Key trends and opportunities
    • 6.5.2 LAMEA Market size and forecast, by Type
    • 6.5.3 LAMEA Market size and forecast, by End User
    • 6.5.4 LAMEA Market size and forecast, by country
      • 6.5.4.1 Brazil
      • 6.5.4.1.1 Market size and forecast, by Type
      • 6.5.4.1.2 Market size and forecast, by End User
      • 6.5.4.2 Saudi Arabia
      • 6.5.4.2.1 Market size and forecast, by Type
      • 6.5.4.2.2 Market size and forecast, by End User
      • 6.5.4.3 South Africa
      • 6.5.4.3.1 Market size and forecast, by Type
      • 6.5.4.3.2 Market size and forecast, by End User
      • 6.5.4.4 Rest of LAMEA
      • 6.5.4.4.1 Market size and forecast, by Type
      • 6.5.4.4.2 Market size and forecast, by End User

CHAPTER 7: COMPANY LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Key developments

CHAPTER 8: COMPANY PROFILES

  • 8.1 B. Braun
    • 8.1.1 Company overview
    • 8.1.2 Company snapshot
    • 8.1.3 Operating business segments
    • 8.1.4 Product portfolio
    • 8.1.5 Business performance
    • 8.1.6 Key strategic moves and developments
  • 8.2 Delta Surgical
    • 8.2.1 Company overview
    • 8.2.2 Company snapshot
    • 8.2.3 Operating business segments
    • 8.2.4 Product portfolio
    • 8.2.5 Business performance
    • 8.2.6 Key strategic moves and developments
  • 8.3 Evonos GmbH & Co. KG
    • 8.3.1 Company overview
    • 8.3.2 Company snapshot
    • 8.3.3 Operating business segments
    • 8.3.4 Product portfolio
    • 8.3.5 Business performance
    • 8.3.6 Key strategic moves and developments
  • 8.4 Integra Life-science Holding Corporation
    • 8.4.1 Company overview
    • 8.4.2 Company snapshot
    • 8.4.3 Operating business segments
    • 8.4.4 Product portfolio
    • 8.4.5 Business performance
    • 8.4.6 Key strategic moves and developments
  • 8.5 Medtronic PLC
    • 8.5.1 Company overview
    • 8.5.2 Company snapshot
    • 8.5.3 Operating business segments
    • 8.5.4 Product portfolio
    • 8.5.5 Business performance
    • 8.5.6 Key strategic moves and developments
  • 8.6 Microport Scientific Corporation
    • 8.6.1 Company overview
    • 8.6.2 Company snapshot
    • 8.6.3 Operating business segments
    • 8.6.4 Product portfolio
    • 8.6.5 Business performance
    • 8.6.6 Key strategic moves and developments
  • 8.7 Mizuho Medical Incorporation
    • 8.7.1 Company overview
    • 8.7.2 Company snapshot
    • 8.7.3 Operating business segments
    • 8.7.4 Product portfolio
    • 8.7.5 Business performance
    • 8.7.6 Key strategic moves and developments
  • 8.8 Spiegelberg
    • 8.8.1 Company overview
    • 8.8.2 Company snapshot
    • 8.8.3 Operating business segments
    • 8.8.4 Product portfolio
    • 8.8.5 Business performance
    • 8.8.6 Key strategic moves and developments
  • 8.9 Stryker Corporation
    • 8.9.1 Company overview
    • 8.9.2 Company snapshot
    • 8.9.3 Operating business segments
    • 8.9.4 Product portfolio
    • 8.9.5 Business performance
    • 8.9.6 Key strategic moves and developments
  • 8.10 Terumo Global (Microvention)
    • 8.10.1 Company overview
    • 8.10.2 Company snapshot
    • 8.10.3 Operating business segments
    • 8.10.4 Product portfolio
    • 8.10.5 Business performance
    • 8.10.6 Key strategic moves and developments
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제